Out-of-pocket cost: This is the amount a person must pay for care when Medicare does not pay the total amount or offer coverage.Costs can include deductibles, coinsurance, copayments, and premiums ...

Pfizer has revealed that its much-anticipated selective oestrogen receptor degrader (SERD) vepdegestrant for breast cancer missed the mark for a key endpoint in its first phase 3 trial readout.